David E Martin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Antimicrobial Resistance

Induced Apoptosis

Respiratory Syncytial Virus

Top Venues

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Jackelyn Murray, David E Martin, Sarah Hosking, Nichole Orr-Burks, Robert J Hogan, Ralph A Tripp
Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice. Viruses 16 (1) (2024)
Harrison C Bergeron, Jackelyn Crabtree, Tamas Nagy, David E Martin, Ralph A Tripp
Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice. Viruses 16 (7) (2024)
Harrison C Bergeron, Jackelyn Crabtree, Tamas Nagy, David E Martin, Ralph A Tripp
Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice. Viruses 16 (7) (2024)
Jackelyn Murray, David E Martin, Sarah Hosking, Nichole Orr-Burks, Robert J Hogan, Ralph A Tripp
Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice. Viruses 16 (1) (2024)
Jackelyn Murray, David E Martin, Sarah Hosking, Nichole Orr-Burks, Robert J Hogan, Ralph A Tripp
Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice. Viruses 16 (1) (2024)
Harrison C Bergeron, Jackelyn Crabtree, Tamas Nagy, David E Martin, Ralph A Tripp
Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice. Viruses 16 (7) (2024)
Jackelyn Murray, David E Martin, Sarah Hosking, Nichole Orr-Burks, Robert J Hogan, Ralph A Tripp
Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice. Viruses 16 (1) (2024)
Ralph A Tripp, David E Martin
Antiviral agents and therapeutics against respiratory viruses. Expert opinion on investigational drugs (2024)
David E Martin, Neelam Pandey, Purvi Chavda, Gurpreet Singh, Rakesh Sutariya, Frederic Sancilio, Ralph A Tripp
Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19. Viruses 15 (7) (2023)
Jackelyn Murray, David E Martin, Fred D Sancilio, Ralph A Tripp
Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication. Viruses 15 (12) (2023)
Jackelyn Murray, David E Martin, Fred D Sancilio, Ralph A Tripp
Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication. Viruses 15 (12) (2023)
Ralph A Tripp, David E Martin
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19. Viruses 15 (11) (2023)
Jackelyn Murray, David E Martin, Fred D Sancilio, Ralph A Tripp
Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication. Viruses 15 (12) (2023)
Ralph A Tripp, David E Martin
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Viruses 14 (3) (2022)
Jackelyn Murray, Harrison C Bergeron, Les P Jones, Zachary Beau Reener, David E Martin, Fred D Sancilio, Ralph A Tripp
Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication. Viruses 14 (5) (2022)